Yahoo Web Search

Search results

    • Johnson & Johnson plans $850M Proteologix acquisition

      NJBIZ· 4 hours ago

      Johnson & Johnson plans to shell out $850 million to acquire Proteologix Inc. The privately held California biotech focuses on bispecific antibodies for immune-mediated diseases. A May 16 press ...